We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Acoustic Assay Launched to Increase Productivity of Protein Analyses

By LabMedica International staff writers
Posted on 03 Jun 2014
Print article
Image: Highly Sensitive Next Generation Acoustic Assays in Complex Sample Matrices (Photo courtesy of Bioscale).
Image: Highly Sensitive Next Generation Acoustic Assays in Complex Sample Matrices (Photo courtesy of Bioscale).
A new, six-plate cartridge format for Acoustic Assays was launched that will enable larger, cost efficient protein analysis studies.

BioScale, Inc., (Lexington, MA, USA) launched a new, six-plate cartridge format for its Acoustic Assays to enable larger protein analysis studies, with unprecedented cost efficiency. The product enhancement, for use on the Bioscale's proprietary ViBE instrumentation platform, will be introduced at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego (CA, USA) which will take place during November 2–6, 2014.

Christopher Silva, vice president, commercial operations at BioScale said, "Our ViBE platform, paired with our nonoptical Acoustic Assays, overcomes limitations of traditional methods like ELISA or Western blot by providing a simple, highly sensitive method of measuring specific proteins in a complex sample, with walk-away automation. This enables fast assay development—that takes days, rather than months." Mr. Silva added, "Now, our new six-plate format enables even larger studies—providing up to 576 data points in one cartridge—at a cost as low as only USD 2 per sample well. This will be particularly important for scientists needing to study cell signaling pathways and biomarkers […]."

BioScale's ViBE platform enables nonoptical, acoustic protein measurement utilizing BioScale's proprietary Acoustic Membrane MicroParticle (AMMP) Acoustic Membrane MicroParticle technology. The company's Acoustic Assays measure analyte concentration by determining changes in oscillation frequency caused by the binding of microparticles to the sensor surface. To date, the platform featured 1-, 2- and 3-plate cartridge formats allowing up to 288 samples per cartridge. Now, the six-plate format allows up to 576 individual data points in a single assay or the reuse of the cartridge for multiple assays for up to 576 measurements across 5 days.

The ViBE platform is a novel protein measurement technology enabling highly sensitive, automated Acoustic Immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The sensitivity, precision, and walk-away capabilities of our non-optical AMMP technology enables customers to achieve breakthrough advancements in protein research that were not previously attainable via traditional ELISA, Western blot and IHC methods, allowing ultra-sensitive detection of proteins in complex biological samples. The company's instrumentation platform is used by leading biopharmaceutical companies, academic institutions and government laboratories.

Related Links:

BioScale, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.